[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100521232":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":32,"locations":38,"responsibleParty":53,"collaborators":18,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":18,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":18,"enrollmentInfo":65,"targetDuration":18,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":18,"overallStatus":40,"whyStopped":18,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Loewenstein Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Pregabalin","EXPERIMENTAL","Pregabalin 75 mg X2",[13],"Drug: Pregabalin 75mg",{"label":15,"type":16,"description":17,"interventionNames":18},"No treatment","NO_INTERVENTION","no treatment",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Pregabalin 75mg","Pregabalin 75 mg twice a day",[9],[26],"Lyrica",[28],{"name":29,"affiliation":30,"role":31},"Amiram Catz, Catz","Loewenstein Rehabilitation Hospital","PRINCIPAL_INVESTIGATOR",[33],{"name":34,"role":35,"phone":36,"phoneExt":18,"email":37},"Amiram Catz, Prof.","CONTACT","972-9-770-9934","amiramc@clalit.org.il",[39],{"facility":30,"status":40,"city":41,"state":18,"zip":18,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Raanana","Israel","IL",{"type":45,"coordinates":46},"Point",[47,48],34.87386,32.1836,{"lat":48,"lon":47},[51],{"name":52,"role":35,"phone":18,"phoneExt":18,"email":18},"Sara Lipkin",{"type":31,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"amiram-catz","Principal Investigator","100521232","prophylactic-pregabalin-treatment-following-spinal-cord-injury-100521232",false,"NCT06066918","Prophylactic Pregabalin Treatment Following Spinal Cord Injury","The Effect of Preventional Drug Therapy on Pain Regulation Mechanisms Among Spinal Cord Injury Patients Who Have Yet to Develop Central Pain","Inclusion Criteria:\n\n* Up to 3 months following traumatic or non-traumatic SCL\n* Ability to give informed consent and cooperate\n\nExclusion Criteria:\n\n* Pregnancy\n* Neurological or other medical conditions that may interfere with sensation\n* Neuropathic-like pain before recruitment (described as painful sensation of electric current, burning, numbness, tingling, pricking, or squeezing)\n* Being treated with Pregabalin\n* Blood creatinine levels \\>1.2 or creatinine clearance \\\u003C60\n* Sensitivity to lactose","ALL","18 Years",{"count":66,"type":67},50,"ESTIMATED","INTERVENTIONAL",[70],"NA","Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.",[73,74],"Spinal Cord Injuries","Spinal Cord Diseases","2025-06-18",{"date":77,"type":78},"2025-06-24","ACTUAL",{"date":80,"type":78},"2021-07-13",{"date":82,"type":67},"2026-02-05",{"name":5,"class":6},1]